Synta Pharmaceuticals CFO Alex Howarth receives $7.1M in 2021
Synta Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Synta Pharmaceuticals reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, six executives at Synta Pharmaceuticals received on average a compensation package of $4.5M, a 17% increase compared to previous year.
Average pay of disclosed executives at Synta Pharmaceuticals
Alex Howarth, Chief Financial Officer, received $7.1M in total. 92% of Howarth's compensation, or $6.5M, was in option awards. Howarth also received $75K in bonus, $241K in non-equity incentive plan, $281K in salary, as well as $7.9K in other compensation.
For fiscal year 2021, the median employee pay was $459,419 at Synta Pharmaceuticals. Therefore, the ratio of Alex Howarth's pay to the median employee pay was 16 to one.
Paul A. Friedman, Chief Executive Officer, received a compensation package of $5.3M, which increased by 17% compared to previous year. 80% of the compensation package, or $4.3M, was in option awards.
Rebecca Taub, Chief Medical Officer, earned $4.6M in 2021, a 19% increase compared to previous year.
Marc R. Schneebaum, Chief Financial Officer, received $3.7M in 2021, which increases by 26% compared to 2020.
Brian J. Lynch, General Counsel, earned $3.4M in 2021, a 23% decrease compared to previous year.
Remy Sukhija, Senior Vice President, Chief Commercial Officer, received $2.8M in 2021, which decreases by 19% compared to 2020.
Related executives
Paul Friedman
Synta Pharmaceuticals
Chief Executive Officer
Rebecca Taub
Synta Pharmaceuticals
Chief Medical Officer
Brian Lynch
Synta Pharmaceuticals
General Counsel
Remy Sukhija
Synta Pharmaceuticals
Senior Vice President, Chief Commercial Officer
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
Marc Schneebaum
Synta Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on May 2, 2022.